Literature DB >> 19117755

Electrochemical activity of holotransferrin and its electrocatalysis-mediated process of artemisinin.

Huai-Hong Cai1, Jiye Cai, Pei-Hui Yang.   

Abstract

Holotransferrin, the iron (III) transport protein in the blood, can significantly increase the anticancer activity of artemisinin, which is isolated from the Chinese plant qinghaosu. This paper investigates the action process of holotransferrin-induced electrocatalytic reduction of artemisinin by spectroscopic and electrochemical techniques. Results show that holotransferrin(Fe(III)) is the electrochemical sites of holotransferrin, which can catalyze the reduction of artemisinin through lowering the overpotential by about 80 mV. Compared with the different electrochemical behaviors of artemisinin with apotransferrin and holoprotein (apotransferrin in the presence of Fe(III)), respectively, it demonstrates that holotransferrin(Fe(III)) plays an important role in the electrocatalytic reduction of artemisinin, which can catalyze the cleavage of the endoperoxide bridge in artemisinin. A reliable two-step process is proposed to explain that artemisinin is activated by holotransferrin(Fe(III))-mediated electrocatalytic reduction. These results can provide further information for better understanding the anticancer action of holotransferrin-conjugated artemisinin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19117755     DOI: 10.1016/j.bmcl.2008.12.004

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells.

Authors:  Colm Morrissey; Byron Gallis; Jeffrey W Solazzi; Byung Ju Kim; Roman Gulati; Funda Vakar-Lopez; David R Goodlett; Robert L Vessella; Tomikazu Sasaki
Journal:  Anticancer Drugs       Date:  2010-04       Impact factor: 2.248

2.  Chemopreventive effect of artesunate in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.

Authors:  Sazal Patyar; Rakesh Raman Patyar; Bikash Medhi; Krishan Lal Khanduja
Journal:  J Adv Pharm Technol Res       Date:  2017 Jul-Sep

3.  Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells.

Authors:  Qiuyan Wang; Shaoling Wu; Xindong Zhao; Chunting Zhao; Hongguo Zhao; Lanfen Huo
Journal:  PLoS One       Date:  2015-10-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.